Literature DB >> 34411476

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report.

Young Joo Park1,2, Hyun Young Woo1,2, Moon Bum Kim3, Jihyun Ahn4, Jeong Heo1,2.   

Abstract

Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated liver enzymes and suspicious cirrhotic nodules on computed tomography. The patient had cirrhosis but did not have portal hypertension. Based on the initial histopathologic finding of chronic granulomatous inflammation and the common clinical characteristics of sarcoidosis, he was initially diagnosed with primary biliary cholangitis, and his daily dosage of ursodeoxycholic acid was increased to 900 mg. After 14 months of treatment, his total serum bilirubin concentration was 10.9 mg/dL (upper normal limit, 1.2 mg/dL). Additionally, a transjugular liver biopsy revealed multiple noncaseating granulomas. He was diagnosed with primary hepatic sarcoidosis involving the lungs, heart, spleen, kidneys, and skin. Treatment with methylprednisolone was initiated. Two weeks later, he was started on azathioprine, and the dose of steroid was simultaneously reduced. These findings indicate the importance of including hepatic sarcoidosis as a possible diagnosis in patients with elevated liver enzymes or cryptogenic cirrhosis.

Entities:  

Keywords:  Biliary tract; Cholestasis; Liver cirrhosis; Sarcoidosis

Year:  2021        PMID: 34411476      PMCID: PMC9273146          DOI: 10.12701/yujm.2021.01151

Source DB:  PubMed          Journal:  J Yeungnam Med Sci        ISSN: 2799-8010


  20 in total

1.  Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis.

Authors:  P S Bunting; J P Szalai; M Katic
Journal:  Clin Biochem       Date:  1987-06       Impact factor: 3.281

2.  Liver-test abnormalities in sarcoidosis.

Authors:  Johanna Cremers; Marjolein Drent; Ann Driessen; Fred Nieman; Petal Wijnen; Robert Baughman; Ger Koek
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-01       Impact factor: 2.566

3.  Hepatic, splenic, and gastrointestinal involvement with sarcoidosis.

Authors:  Marc A Judson
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

4.  Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients.

Authors:  W C Maddrey; C J Johns; J K Boitnott; F L Iber
Journal:  Medicine (Baltimore)       Date:  1970-09       Impact factor: 1.889

5.  Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Douglas A Simonetto; Eric L Matteson
Journal:  Am J Gastroenterol       Date:  2017-09-05       Impact factor: 10.864

Review 6.  Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options.

Authors:  Umer Syed; Hassan Alkhawam; Mena Bakhit; Rafael A Ching Companioni; Aron Walfish
Journal:  Scand J Gastroenterol       Date:  2016-05-13       Impact factor: 2.423

Review 7.  Hepatic sarcoidosis.

Authors:  Alexandros Karagiannidis; Maria Karavalaki; Anastasios Koulaouzidis
Journal:  Ann Hepatol       Date:  2006 Oct-Dec       Impact factor: 2.400

Review 8.  Clinical presentation and protocol for management of hepatic sarcoidosis.

Authors:  Jamak Modaresi Esfeh; Daniel Culver; Thomas Plesec; Binu John
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-12-04       Impact factor: 3.869

Review 9.  Atypical sarcoidosis: case reports and review of the literature.

Authors:  M Giovinale; C Fonnesu; A Soriano; C Cerquaglia; V Curigliano; E Verrecchia; G De Socio; G Gasbarrini; R Manna
Journal:  Eur Rev Med Pharmacol Sci       Date:  2009-03       Impact factor: 3.507

Review 10.  Hepatic Sarcoidosis.

Authors:  Micheal Tadros; Faripour Forouhar; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.